MARKET

ORPOF

ORPOF

Ose Immunotherapeutics Sa
OTCPK
11.60
NaN%
Closed 09:30 03/05 EST
OPEN
--
PREV CLOSE
11.60
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
11.60
52 WEEK LOW
11.60
MARKET CAP
260.04M
P/E (TTM)
-6.2178
1D
5D
1M
3M
1Y
5Y
1D
OSE Immunotherapeutics replaces CEO Nicolas Poirier, appoints Marc Le Bozec as interim CEO
Seeking Alpha · 10/03/2025 07:35
About ORPOF
OSE Immunotherapeutics SA, formerly Orphan Synergy Europe Pharma SA, is a France-based company, engaged in clinical stage biotechnological sector. It develops immunotherapies, directly or through partnerships, for the activation and regulation of the immune system in immuno-oncology and in autoimmune diseases. The Company's research and development in immunology is based on 3 platforms, such as T cell-based vaccines, Immuno-Oncology (myeloid targets) and Auto-Immunity & Inflammation. It provides technological and scientific platforms: neoepitopes, agonist or antagonist monoclonal antibodies, ideally positioned to fight cancer and autoimmune diseases.

Webull offers Ose Immunotherapeutics SA stock information, including OTCPK: ORPOF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ORPOF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ORPOF stock methods without spending real money on the virtual paper trading platform.